Want to see GB:EMVC full AI Analyst Report?
Top Page
NetScientific
(LSE:EMVC)
Select Model
Select Model
Rating:50Neutral
Price Target:
48.00 p
▼(-5.88% Downside)
Action:Reiterated
Date:08/20/26
The score is held back primarily by weak financial performance, especially persistent cash burn and ongoing operating losses despite improving revenue trends and a near-breakeven net result. Technical indicators are moderately supportive and provide some offset, but valuation remains challenged given negative earnings and no dividend support.
Positive Factors
Revenue Growth
Sustained revenue expansion, even from a small base, can broaden the portfolio platform’s commercialization potential and improve operating leverage if investment activity and portfolio support scale efficiently.
Negative Factors
Persistent Cash Burn
Continued operating and free-cash-flow deficits show that the business is not self-funding. Reliance on external capital or existing resources can constrain follow-on investment and increase execution risk over the medium term.
Read all positive and negative factors
Positive Factors
Negative Factors
Revenue Growth
Sustained revenue expansion, even from a small base, can broaden the portfolio platform’s commercialization potential and improve operating leverage if investment activity and portfolio support scale efficiently.
Read all positive factors
NetScientific (EMVC) vs. iShares MSCI United Kingdom ETF (EWC)
Market Cap
£13.56M
Dividend YieldN/A
Average Volume (3M)11.89K
Price to Earnings (P/E)―
Beta (1Y)0.56
Revenue Growth16.98%
EPS Growth99.21%
CountryUK
Employees21
SectorFinancial
Sector Strength70
IndustryAsset Management
Share Statistics
EPS (TTM)>-0.01
Shares Outstanding27,967,531
10 Day Avg. Volume15,862
30 Day Avg. Volume11,886
Financial Highlights & Ratios
PEG Ratio5.74
Price to Book (P/B)1.04
Price to Sales (P/S)5.52
P/FCF Ratio-12.43
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)-0.03
Revenue Forecast (FY)£3.43M
NetScientific Business Overview & Revenue Model
Company Description
EMV Capital plc operates as a venture capital firm, primarily targeting investments across the full spectrum of early-stage funding, from seed rounds through to mid-stage and growth capital. Its investment mandate spans diverse high-growth sectors...
How the Company Makes Money
NetScientific generally makes money through value creation in its portfolio companies rather than through sales of a single operating product. Its primary economic model is (i) equity ownership in portfolio companies and (ii) realizing gains when ...
NetScientific Financial Statement Overview
Summary
Income Statement
38
Negative
Balance Sheet
62
Positive
Cash Flow
28
Negative
| Breakdown | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 2.87M | 2.45M | 1.45M | 1.00M | 1.11M |
| Gross Profit | 2.25M | 2.09M | 1.23M | 782.00K | 989.00K |
| EBITDA | -1.52M | -3.12M | -2.27M | -3.31M | -2.65M |
| Net Income | -21.00K | -3.06M | -2.64M | -3.09M | -2.38M |
Balance Sheet | |||||
| Total Assets | 19.78M | 19.50M | 22.46M | 28.95M | 20.69M |
| Cash, Cash Equivalents and Short-Term Investments | 511.00K | 949.00K | 347.00K | 580.00K | 2.35M |
| Total Debt | 2.60M | 1.53M | 2.53M | 1.25M | 654.00K |
| Total Liabilities | 6.13M | 5.43M | 5.35M | 3.71M | 2.18M |
| Stockholders Equity | 15.21M | 15.10M | 17.83M | 25.84M | 18.50M |
Cash Flow | |||||
| Free Cash Flow | -1.27M | -1.97M | -3.51M | -3.16M | -3.54M |
| Operating Cash Flow | -1.24M | -1.78M | -3.14M | -2.56M | -3.48M |
| Investing Cash Flow | 279.00K | 12.00K | 1.11M | -1.08M | -3.46M |
| Financing Cash Flow | 477.00K | 2.57M | 1.39M | 1.74M | 8.02M |
NetScientific Technical Analysis
Negative
51.00
Price Trends
52.53
Negative
50.27
Negative
53.03
Negative
Market Momentum
-1.09
Positive
9.99
Positive
20.74
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For GB:EMVC, the sentiment is Negative. The current price of 51 is below the 20-day moving average (MA) of 51.90, below the 50-day MA of 52.53, and below the 200-day MA of 53.03, indicating a bearish trend. The MACD of -1.09 indicates Positive momentum. The RSI at 9.99 is Positive, neither overbought nor oversold. The STOCH value of 20.74 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for GB:EMVC.
NetScientific Peers Comparison
UnderperformOutperform
Sector (68)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
68 Neutral | $18.00B | 11.42 | 9.92% | 3.81% | 9.73% | 1.22% | |
62 Neutral | £16.71M | 4.76 | 23.41% | ― | 543.02% | 30.22% | |
50 Neutral | £13.56M | -478.00 | -0.14% | ― | 16.98% | 99.21% | |
43 Neutral | £15.16M | -1.17 | -19.23% | ― | 7.43% | -51.54% | |
42 Neutral | £19.15M | -2.93 | -25.29% | ― | 8.61% | 39.01% |
* Financial Sector Average
GB:EMVC
NetScientific
47.80
5.80
13.81%
GB:FIPP
Frontier IP
13.25
-4.75
-26.39%
GB:MAFL
Mineral & Financial Investments
44.50
16.50
58.93%
GB:TEAM
TEAM plc
15.50
-20.50
-56.94%
NetScientific Corporate Events
Business Operations and Strategy
EMV Capital to spotlight AMR Bio and ProAxsis in investor portfolio showcase
Positive
Jul 13, 2026
EMV Capital plc, the AIM-quoted deep tech and life sciences venture capital group, is organising a virtual Meet the Portfolio event to showcase two of its investments, AMR Bio and ProAxsis, to existing and prospective investors. The online session...
Business Operations and StrategyFinancial DisclosuresPrivate Placements and Financing
EMV Capital reshapes Glycotest and ProAxsis stakes as portfolio shifts to associate model
Positive
Jul 1, 2026
EMV Capital has led a $3.22 million first-close fundraising for U.S.-based diagnostics firm Glycotest and overseen a share capital reorganisation at ProAxsis ahead of an up to £1 million equity raise, resulting in both portfolio companies no ...
Business Operations and StrategyShareholder Meetings
EMV Capital Secures Shareholder Backing for All AGM Resolutions
Positive
Jun 17, 2026
EMV Capital plc said that all resolutions proposed at its 2026 annual general meeting were duly passed, including the adoption of its 2025 accounts, approval of the directors’ remuneration report and reappointment of BDO as auditor. Sharehol...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.